Suppr超能文献

顺铂与癌症化疗中的DNA修复

Cisplatin and DNA repair in cancer chemotherapy.

作者信息

Zamble D B, Lippard S J

机构信息

Department of Chemistry, Massachusetts Institute of Technology, Cambridge 02139, USA.

出版信息

Trends Biochem Sci. 1995 Oct;20(10):435-9. doi: 10.1016/s0968-0004(00)89095-7.

Abstract

Cisplatin, a DNA-damaging agent, is one of the most widely used anticancer drugs. As with all members of this class of chemotherapeutic compounds, the clinical success of cisplatin is compromised if tumor cells become resistant by various mechanisms, including enhanced DNA repair. In addition to its role in resistance, DNA repair has been linked to the cytotoxic mechanism of cisplatin. DNA damaged by the drug has proved to be a valuable tool for exploring the details of the nucleotide excision repair pathway.

摘要

顺铂是一种能损伤DNA的药物,是使用最为广泛的抗癌药物之一。与这类化疗化合物的所有成员一样,如果肿瘤细胞通过包括增强DNA修复在内的各种机制产生耐药性,顺铂的临床疗效就会受到影响。除了在耐药性方面的作用外,DNA修复还与顺铂的细胞毒性机制有关。药物损伤的DNA已被证明是探索核苷酸切除修复途径细节的一个有价值的工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验